Senior Scientist - Pharmaceutical Development

Do you have expertise in, and passion for analytical science? Would you like to apply your expertise and be part of a company that follows the science and turns ideas into life changing medicines? Then this role might be the one for you! 

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious disease.

Pharmaceutical Technology and Development (PT&D) sits within Operation and we are the bridge between forward-thinking science and innovative medicines that help millions of people. We work across the entire value chain, designing and delivering active ingredients, formulations and devices required to support new medicines – from supplies for use in early toxicology studies and clinical trials to developing the technology to ensure drugs can be scaled up for commercial manufacture. 

We are currently looking for an Analytical Senior Scientist in Global Product Development (GPD) within PT&D. Our vision is to transform product design and development to enable us to deliver new medicines to patients. We’re looking for a skilled and motivated senior scientist to join one of our analytical teams in Gothenburg, Sweden. This is an exciting opportunity where you will be key in developing our products, taking the next step into the future.  

What you’ll do 

You will work in a highly advanced research environment supporting the analytical development and strategy, enabling the progression of drug product projects. You will apply your analytical expertise in projects while working closely with cross-functional teams of formulation scientists, biopharmaceutics, process engineers and your work will contribute significantly to Chemistry, Manufacturing, Control (CMC) aspects.

Other responsibilities include, but are not limited to: 

• Combination of hands-on laboratory work with thought-leadership.  

• Independently performing analyses for drug product characterization and stability, troubleshoot challenging technical issues, and uphold data integrity and compliance standards. 

• Leading and contributing to analytical method development and lifecycle management—driving experimental design, qualification, and validation approaches, while providing guidance within the analytical team to align on standard processes and deliver to program milestones.  

• Where appropriate, you will leverage digital tools and advanced analytics to support robust science, efficient workflows, and clear decision-making. 

Essential requirements 

To succeed in this role, you will be an experienced analyst skilled in developing oral or inhaled products, with strong digital proficiency in modern data and AI tools. Expertise in analytical chemistry and laboratory work, including leading method development, validation, and troubleshooting, is required. Excellent skills in written and verbal communication, and the ability to engage and collaborate proactively across boundaries together with a positive problem-solving attitude and strong delivery focus is essential.   

• ​PhD in Analytical Chemistry or other relevant scientific subject area with experience in the field; alternatively, BSc or MSc degree combined with a few years of industrial work experience. 

• Extensive experience in analytical development for oral or inhaled products together with hands on experience of oral or inhaled drug product characterization techniques. 

• In-depth scientific knowledge and handson experience within analytical sciences and technically skilled with analytical separation techniques such as liquid chromatography (UPLC) for small and/or large molecules such as protein. 

• Strong proficiency in method development and validation of analytical methods. 

• Strong data analysis skills, with the ability to interpret results and communicate findings effectively to stakeholders. 

• Proven ability to solve technical challenges and problems. 

• Demonstrated proactivity in identifying and owning tasks, and strong collaboration skills when working across cross-functional teams to deliver high-quality, timely results.

• Excellent communication skills and a proven track record of working collaboratively to develop innovative solutions

• Strong leadership skills including the ability to deliver robust scientific contributions to projects and utilise risk-based approaches to project delivery 

• Strong ambition to develop yourself and others. 

• Comfortable working within a modern digital laboratory environment (basic data visualization/statistics) to support high-quality, compliant science. 

• Knowledge and willingness in using AI tools  

Desirable requirements  

• Extensive experience in analytical development for oral and inhaled products together. 

• Project leadership  

• Experience working in a GMP environment, working with ELN and LIMS as well as knowledge regarding instrument/equipment maintenance procedures. 

• Experience with analytical methodologies for oligonucleotides, peptide and proteins characterisation (e.g., capillary electrophoresis, ion-exchange chromatography, ELISA, SDS-PAGE). 

• Experience in aerosol characterization techniques used for inhaled products, such as impactor analysis. 

• Experience of analysis of oral drug products, such as dissolution, disintegration and Karl Fisher analysis 

At AstraZeneca, we’re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There’s no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration, and always committed to lifelong learning, growth and development. We’re on an exciting journey to pioneer the future of healthcare.

We work, on average, a minimum of three days per week from the office. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world and apply now!

We welcome your application no later than 20th March 2026!